BAILLIE GIFFORD & CO 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-07 07:01 am Purchase | 2024-02-29 | 13G | Sana Biotechnology, Inc. SANA | BAILLIE GIFFORD & CO | 10,360,620 4.700% | 210,603 (+2.07%) | Filing |
| 2024-01-26 06:49 am Sale | 2023-12-29 | 13G | Sana Biotechnology, Inc. SANA | BAILLIE GIFFORD & CO | 10,150,017 5.150% | -614,710 (-5.71%) | Filing |
| 2023-01-20 07:41 am Sale | 2022-12-30 | 13G | Sana Biotechnology, Inc. SANA | BAILLIE GIFFORD & CO | 10,764,727 5.640% | -497,303 (-4.42%) | Filing |
| 2022-01-26 07:03 am Purchase | 2021-12-31 | 13G | Sana Biotechnology, Inc. SANA | BAILLIE GIFFORD & CO | 11,262,030 5.960% | 11,262,030 (New Position) | Filing |